Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Differences between professionals in treatment planning for patients with stage III lung cancer using treatment-planning QA software.
Sato D, Sasaki M, Nakaguchi Y, Kamomae T, Kawanaka T, Kubo A, Tonoiso C, Kanazawa Y, Oita M, Kajino A, Tsuzuki A, Ikushima H. Sato D, et al. Among authors: kawanaka t. Rep Pract Oncol Radiother. 2023 Nov 16;28(5):671-680. doi: 10.5603/rpor.97511. eCollection 2023. Rep Pract Oncol Radiother. 2023. PMID: 38179286 Free PMC article.
Feasibility of accelerated partial breast irradiation with strut-adjusted volume implant brachytherapy in Japan focusing on dosimetry and acute toxicity: a Japanese multi-institutional prospective study.
Yoshida M, Yoshimura RI, Notake R, Shinjo H, Miyaura K, Kuwayama T, Kawanaka T, Shien T, Yoshio K, Shiga T, Kaneyasu Y, Nakagawa T, Kubota K, Nakamura S, Itami J; Working group of APBI with SAVIs in Japan (WASAVIs). Yoshida M, et al. Among authors: kawanaka t. Breast Cancer. 2024 Jan;31(1):75-83. doi: 10.1007/s12282-023-01513-x. Epub 2023 Oct 21. Breast Cancer. 2024. PMID: 37865624
Prostate-specific Antigen Levels Following Brachytherapy Impact Late Biochemical Recurrence in Japanese Patients With Localized Prostate Cancer.
Ueno Y, Fukumori T, Kusuhara Y, Fukawa T, Tsuda M, Daizumoto K, Sasaki Y, Tomida R, Yamamoto Y, Yamaguchi K, Tonoiso C, Kubo A, Kawanaka T, Furutani S, Ikushima H, Takahashi M, Kanayama HO. Ueno Y, et al. Among authors: kawanaka t. In Vivo. 2023 Mar-Apr;37(2):738-746. doi: 10.21873/invivo.13136. In Vivo. 2023. PMID: 36881090 Free PMC article.
Absolute Lymphocyte Count Changes During Neoadjuvant Chemotherapy are Associated With Prognosis of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Patients.
Miyamoto N, Inoue H, Inui T, Sasa S, Aoyama M, Okumura K, Toba H, Hino N, Nishisho A, Yukishige S, Kawanaka T, Takizawa H, Tangoku A. Miyamoto N, et al. Among authors: kawanaka t. Clin Breast Cancer. 2023 Apr;23(3):e68-e76. doi: 10.1016/j.clbc.2023.01.005. Epub 2023 Jan 12. Clin Breast Cancer. 2023. PMID: 36682907
Appropriate management reduces radiation exposure in daily urological practice.
Ozaki K, Fukawa T, Kawanaka T, Daizumoto K, Sasaki Y, Ueno Y, Tsuda M, Kusuhara Y, Yamamoto Y, Yamaguchi K, Takahashi M, Kanayama HO. Ozaki K, et al. Among authors: kawanaka t. Int J Urol. 2022 Oct;29(10):1207-1212. doi: 10.1111/iju.14971. Epub 2022 Jul 18. Int J Urol. 2022. PMID: 35851694
Extreme leanness, lower skeletal muscle quality, and loss of muscle mass during treatment are predictors of poor prognosis in cervical cancer treated with concurrent chemoradiation therapy.
Abe A, Yuasa M, Imai Y, Kagawa T, Mineda A, Nishimura M, Tonoiso C, Kubo A, Kawanaka T, Ikushima H, Iwasa T. Abe A, et al. Among authors: kawanaka t. Int J Clin Oncol. 2022 May;27(5):983-991. doi: 10.1007/s10147-022-02140-w. Epub 2022 Feb 25. Int J Clin Oncol. 2022. PMID: 35212828
46 results